Literature DB >> 18800986

Altered homeostasis of CD4(+) FoxP3(+) regulatory T-cell subpopulations in systemic lupus erythematosus.

Jau-Ling Suen1, Hsiao-Ting Li, Yuh-Jyh Jong, Bor-Luen Chiang, Jeng-Hsien Yen.   

Abstract

The role of naturally occurring regulatory T cells (Treg), known to be phenotypically heterogeneous, in controlling the expression of systemic lupus erythematosus (SLE) is incompletely defined. Therefore, different subpopulations of CD4(+) FoxP3(+) Tregs in patients with active or inactive SLE were investigated and compared with those of healthy subjects and patients with ankylosing spondylitis (AS). Characterization of different subsets of circulating CD4(+) FoxP3(+) Tregs was examined using flow cytometry. CD4(+) CD25(high) T cells were sorted and examined for suppressive activity in vitro. The results showed first that a significant decrease in the frequency of CD4(+) CD25(high) FoxP3(+) T cells was present in patients with active SLE (n = 58), compared with healthy controls (n = 36) and AS patients (n = 23). In contrast, the frequencies of CD25(low) FoxP3(+) and CD25(-) FoxP3(+) CD4(+) T cells were significantly increased in patients with active SLE by comparison with the control subjects. The elevation of these two putative Treg subpopulations was associated with lower plasma levels of complement C3 and C4 in patients with SLE. In addition, the ratios of the three subsets of CD4(+) FoxP3(+) Tregs versus effector T cells (CD4(+) CD25(+) FoxP3(-)) were inversely correlated with the titer of anti-double-stranded DNA IgG in patients with inactive, but not active, SLE. These results suggest that the pathogenesis of SLE may be associated with a defect in the homeostatic control of different Treg subsets.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18800986      PMCID: PMC2691785          DOI: 10.1111/j.1365-2567.2008.02937.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  35 in total

1.  Inducing and expanding regulatory T cell populations by foreign antigen.

Authors:  Karsten Kretschmer; Irina Apostolou; Daniel Hawiger; Khashayarsha Khazaie; Michel C Nussenzweig; Harald von Boehmer
Journal:  Nat Immunol       Date:  2005-10-23       Impact factor: 25.606

2.  In vivo peripheral expansion of naive CD4+CD25high FoxP3+ regulatory T cells in patients with multiple myeloma.

Authors:  Marc Beyer; Matthias Kochanek; Thomas Giese; Elmar Endl; Martin R Weihrauch; Percy A Knolle; Sabine Classen; Joachim L Schultze
Journal:  Blood       Date:  2006-01-12       Impact factor: 22.113

3.  CD4+CD25high regulatory cells in human peripheral blood.

Authors:  C Baecher-Allan; J A Brown; G J Freeman; D A Hafler
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

4.  Global natural regulatory T cell depletion in active systemic lupus erythematosus.

Authors:  Makoto Miyara; Zahir Amoura; Christophe Parizot; Cécile Badoual; Karim Dorgham; Salim Trad; Dominique Nochy; Patrice Debré; Jean-Charles Piette; Guy Gorochov
Journal:  J Immunol       Date:  2005-12-15       Impact factor: 5.422

5.  Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus.

Authors:  Jyh-Hong Lee; Li-Chieh Wang; Yu-Tsan Lin; Yao-Hsu Yang; Dong-Tsamn Lin; Bor-Luen Chiang
Journal:  Immunology       Date:  2006-02       Impact factor: 7.397

Review 6.  How corticosteroids control inflammation: Quintiles Prize Lecture 2005.

Authors:  Peter J Barnes
Journal:  Br J Pharmacol       Date:  2006-06       Impact factor: 8.739

7.  Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development.

Authors:  Marc A Gavin; Troy R Torgerson; Evan Houston; Paul DeRoos; William Y Ho; Asbjørg Stray-Pedersen; Elizabeth L Ocheltree; Philip D Greenberg; Hans D Ochs; Alexander Y Rudensky
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-14       Impact factor: 11.205

8.  The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs.

Authors:  Sarah E Allan; Laura Passerini; Rosa Bacchetta; Natasha Crellin; Minyue Dai; Paul C Orban; Steven F Ziegler; Maria Grazia Roncarolo; Megan K Levings
Journal:  J Clin Invest       Date:  2005-10-06       Impact factor: 14.808

9.  Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells.

Authors:  Nabila Seddiki; Brigitte Santner-Nanan; Jeff Martinson; John Zaunders; Sarah Sasson; Alan Landay; Michael Solomon; Warwick Selby; Stephen I Alexander; Ralph Nanan; Anthony Kelleher; Barbara Fazekas de St Groth
Journal:  J Exp Med       Date:  2006-07-03       Impact factor: 14.307

10.  CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells.

Authors:  Weihong Liu; Amy L Putnam; Zhou Xu-Yu; Gregory L Szot; Michael R Lee; Shirley Zhu; Peter A Gottlieb; Philipp Kapranov; Thomas R Gingeras; Barbara Fazekas de St Groth; Carol Clayberger; David M Soper; Steven F Ziegler; Jeffrey A Bluestone
Journal:  J Exp Med       Date:  2006-07-03       Impact factor: 14.307

View more
  33 in total

Review 1.  Treg cells in autoimmunity: from identification to Treg-based therapies.

Authors:  Lisa Göschl; Clemens Scheinecker; Michael Bonelli
Journal:  Semin Immunopathol       Date:  2019-04-05       Impact factor: 9.623

Review 2.  Could Lymphocyte Profiling be Useful to Diagnose Systemic Autoimmune Diseases?

Authors:  Guillermo Carvajal Alegria; Pierre Gazeau; Sophie Hillion; Claire I Daïen; Divi Y K Cornec
Journal:  Clin Rev Allergy Immunol       Date:  2017-10       Impact factor: 8.667

3.  Altered frequency and phenotype of CD4+ forkhead box protein 3+ T cells and its association with autoantibody production in human immunodeficiency virus-infected paediatric patients.

Authors:  R J Argüello; J Balbaryski; G Barboni; M Candi; E Gaddi; S Laucella
Journal:  Clin Exp Immunol       Date:  2012-05       Impact factor: 4.330

4.  Cathepsin K Deficiency Ameliorates Systemic Lupus Erythematosus-like Manifestations in Faslpr Mice.

Authors:  Yi Zhou; Huimei Chen; Li Liu; Xueqing Yu; Galina K Sukhova; Min Yang; Vasileios C Kyttaris; Isaac E Stillman; Bruce Gelb; Peter Libby; George C Tsokos; Guo-Ping Shi
Journal:  J Immunol       Date:  2017-01-16       Impact factor: 5.422

5.  TCR usage, gene expression and function of two distinct FOXP3(+)Treg subsets within CD4(+)CD25(hi) T cells identified by expression of CD39 and CD45RO.

Authors:  Lingying Ye; Jane C Goodall; Libin Zhang; Ekaterina V Putintseva; Brian Lam; Lei Jiang; Wei Liu; Jian Yin; Li Lin; Ting Li; Xin Wu; Giles Yeo; Mikhail Shugay; Dmitriy M Chudakov; Hill Gaston; Huji Xu
Journal:  Immunol Cell Biol       Date:  2015-10-15       Impact factor: 5.126

6.  Regulatory T cell subsets in children with systemic lupus erythematosus.

Authors:  Azza A Eltayeb; Douaa M Sayed; Noha A Afifi; Maggie A Ibrahim; Tahra M Sheref
Journal:  Clin Rheumatol       Date:  2014-05-27       Impact factor: 2.980

Review 7.  CD4+FOXP3+ T regulatory cells in human autoimmunity: more than a numbers game.

Authors:  S Alice Long; Jane H Buckner
Journal:  J Immunol       Date:  2011-09-01       Impact factor: 5.422

8.  The Nature of Increased Circulating CD4CD25Foxp3 T Cells in Patients with Systemic Lupus Erythematosus: A Novel Hypothesis.

Authors:  Bing Yan; Yi Liu
Journal:  Open Rheumatol J       Date:  2009-06-09

Review 9.  Interferon alpha in systemic lupus erythematosus.

Authors:  Timothy B Niewold; Daniel N Clark; Rafah Salloum; Brian D Poole
Journal:  J Biomed Biotechnol       Date:  2010-06-29

Review 10.  Regulatory T cells in inflammatory bowel diseases and colorectal cancer.

Authors:  Györgyi Műzes; Béla Molnár; Ferenc Sipos
Journal:  World J Gastroenterol       Date:  2012-10-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.